TRIM21 and COVID-19: In one case (23) anti-Ro52 antibodies, which are associated with rapidly progressive ILD and worse prognosis (51), were also present; the woman succumbed to macrophage activation syndrome, and there’s no reason to attribute her death to COVID-19, since anti-MDA5 syndrome appeared two months after recovery from the infection.